Modulakgotla Sebe - Tembisa Hospital, The Aurum Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 16 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Prospective, Randomised, Open Label Phase 2b Dose-Finding trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

Lilian Tina Minja, Isabella van der Feltz,Christina Manyama,Stellah Mpagama,Francis Mhimbira,Ivan Noreña,Modulakgotla Sebe,Mohammed Rassool,Robert Wallis,Nyanda Elias Ntinginya,Alphonce Liyoyo, Beno Mbeya, Larissa Wagnerberger, Tresphory Zumba, Daud D. Peter, Heeran Makkan, Derek J. Sloan,Lindsey te Brake,Jodie Schildkraut,Rob E. Aarnoutse,Timothy D. McHugh, Leticia Wildner,Martin Boeree, Lawrence Geiter, Young-Lag Cho, Brian Aldana, Patrick PJ Phillips,Michael Hoelscher,Elin M. Svensson,Norbert Heinrich, PanACEA Consortium Group

crossref（2024）

Cited0Views0Bibtex

A Phase IIb, Open-Label, Randomized Controlled Dose Ranging Multi-Centre Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of Delpazolid in Combination with Bedaquiline Delamanid Moxifloxacin in Adult Subjects with Newly Diagnosed, Uncomplicated, Smear-Positive, Dr..

A Dierig,M Hoelscher, S Schultz, L Hoffmann, A Jarchow-MacDonald,EM Svensson,L Te Brake,R Aarnoutse,M Boeree, TD McHugh,LM Wildner, X Gong, PPJ Phillips, LT Minja,N Ntinginya, S Mpagama, A Liyoyo,RS Wallis,M Sebe, FA Mhimbira, B Mbeya,M Rassool, L Geiter, YL Cho,N Heinrich

TRIALSno. 1 (2023)

Cited4Views0WOSBibtex

Lung and Blood Early Biomarkers for Host-Directed Tuberculosis Therapies: Secondary Outcome Measures from a Randomized Controlled Trial

Robert S. Wallis,Sibuse Ginindza,Trevor Beattie,Nishanee Arjun,Morongwe Likoti,Modulakgotla Sebe,Vinodh A. Edward,Mohammed Rassool,Khatija Ahmed,Katherine Fielding,Bintou A. Ahidjo,Mboyo D. T. Vangu,Gavin Churchyard

PLOS ONE（2022）

Cited7Views0WOSBibtex

HIV Incidence among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use

Helen Rees,Matthew Francis Chersich,Richard J. Munthali,William Brumskine,Thesla Palanee-Phillips,Busi Nkala,Khatija Ahmed,Modulakgotla Sebe,Zonke Mabude,Maphoshane Nchabeleng,Linda-Gail Bekker,Philip Kotze, Thembisile Mogodiri, Ishana Naidoo,Ravindre Panchia,Landon Myer,Carl Lombard,Gustavo F. Doncel,Glenda Gray,Sinead Delany-Moretlwe

JAIDS Journal of Acquired Immune Deficiency Syndromesno. 4 (2021): 376-383

Cited2Views0WOSBibtex

Adjunctive Host-Directed Therapies for Pulmonary Tuberculosis: a Prospective, Open-Label, Phase 2, Randomised Controlled Trial

Robert S. Wallis,Sibuse Ginindza,Trevor Beattie,Nishanee Arjun,Modulakgotla Sebe,Morongwe Likoti,Vinodh A. Edward,Mohammed Rassool,Khatija Ahmed,Katherine Fielding,Bintou A. Ahidjo,Mboyo D. T. Vangu,Gavin Churchyard

The Lancet Respiratory Medicineno. 8 (2021): 897-908

Cited76Views0WOSBibtex

Alum-Adjuvanted Protein Administered In Combination With Alvac-Hiv Downregulates Early Serum Cytokine Responses To The Vaccine Whereas Mf59 Enhances The Early Cytokine Burst

E. Andersen-Nissen, V. Voillet, A. Naidoo, J. Kee,A. Fiore-Gartland,O. Dintwe,N. Grunenberg,L. Polakowski, L. Fleurs,I. Jani,M. Sebe,F. Laher,L. Stranix-Chibanda,N. Naicker,K. Mngadi

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2021）

Cited0Views0Bibtex

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C Gp120-Mf59 in Adults

Glenda E. Gray,Linda-Gail Bekker,Fatima Laher,Mookho Malahleha,Mary Allen,Zoe Moodie,Nicole Grunenberg,Yunda Huang,Doug Grove,Brittany Prigmore,Jia J. Kee,David Benkeser,John Hural,Craig Innes,Erica Lazarus,Graeme Meintjes,Nivashnee Naicker,Dishiki Kalonji,Maphoshane Nchabeleng,Modulakgotla Sebe,Nishanta Singh,Philip Kotze,Sheetal Kassim,Thozama Dubula,Vimla Naicker,William Brumskine, Cleon N. Ncayiya,Amy M. Ward,Nigel Garrett, Girisha Kistnasami,Zakir Gaffoor,Pearl Selepe, Philisiwe B. Makhoba,Matsontso P. Mathebula,Pamela Mda,Tania Adonis,Katlego S. Mapetla, Bontle Modibedi, Tricia Philip, Gladys Kobane,Carter Bentley,Shelly Ramirez,Simbarashe Takuva,Megan Jones,Mpho Sikhosana,Millicent Atujuna,Michele Andrasik,Nima S. Hejazi,Adrian Puren,Lubbe Wiesner,Sanjay Phogat, Carlos Diaz Granados,Marguerite Koutsoukos,Olivier van der Meeren,Susan W. Barnett,Niranjan Kanesa-Thasan,James G. Kublin,M. Juliana McElrath,Peter B. Gilbert,Holly Janes,Lawrence Corey

New England Journal of Medicine（2021）

Cited156Views0WOSBibtex

156

Once-weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Patients with HIV Taking Dolutegravir-Based Antiretroviral Therapy: a Phase 1/2 Trial

Kelly E. Dooley,Radojka M. Savic,Akshay Gupte,Mark A. Marzinke,Nan Zhang,Vinodh A. Edward,Lisa Wolf,Modulakgotla Sebe,Morongwe Likoti, Mark J. Fyvie, Innocent Shibambo,Trevor Beattie,Richard E. Chaisson,Gavin J. Churchyard

The Lancet HIV（2020）

Cited46Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn